Comparison of Gadomer-17 and gadopentetate dimeglumine for differentiation of benign from malignant breast tumors with MR imaging

Academic Radiology

Volumn 7, Issue 11, 2000, Pages 934-944

  Daldrup Link, Heike E ^a,b,c   Shames, David M ^a   Wendland, Michael ^a   Mühler, Andreas ^a   Gossmann, Axel ^a   Rosenau, Werner ^a   Brasch, Robert C ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c BAYER PHARMA AG   (Germany)

Author keywords

Breast neoplasms; Contrast agents; Experimental; Gadolinium; Magnetic resonance (MR); MR

Indexed keywords

CONTRAST MEDIUM; ETHYLNITROSOUREA; GADOLINIUM PENTETATE MEGLUMINE; GADOMER 17; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL PERMEABILITY; BREAST CANCER; BREAST CARCINOMA; BREAST FIBROADENOMA; BREAST TUMOR; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; FEMALE; IMAGE ANALYSIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMA VOLUME; PRIORITY JOURNAL; RAT;

EID: 0033762462     PISSN: 10766332     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1076-6332(00)80175-0     Document Type: Article

References (47)

1. MR imaging of the breast: Fast imaging sequences with and without Gd-DTPA
2. Contrast enhanced MR imaging of the breast: Survey of 1,200 patient examinations
3. Contrast enhanced MR imaging of the breast
4. False positive cases in dynamic MR mammography
5. Reducing false positive gadolinium enhanced breast MRI results through parameter analysis of the enhancement profile
6. Suspicious breast lesions: MR imaging with pathologic correlation
7. Albumin labeled with Gd-DTPA as an intravascular, blood pool-enhancing agent for MR imaging: Biodistribution and imaging studies
8. Comparison of Gd-DTPA and a macromolecular agent
9. Measurement of capillary permeability to macromolecules by dynamic magnetic resonance imaging: A quantitative non-invasive technique
10. Quantification of capillary permeability to macromolecular magnetic resonance imaging contrast media in experimental mammary adenocarcinomas
11. Contrast enhanced MRI estimation of altered capillary permeability in experimental mammary carcinomas following x-irradiation
12. Dynamic contrast enhanced MR imaging of the upper abdomen: Enhancement properties of gadobutol, gadolinium-DTPA-polylysine, and Gd-DTPA-cascade-polymer
13. 24-gadolinium-cascade-polymer: A potential blood-pool contrast agent for MR-imaging
14. Dendrimer-based metal chelates: A new class of magnetic resonance imaging contrast agents
15. Differentiation of spontaneous canine breast tumors using dynamic magnetic resonance imaging with 24-Gadolinium-DTPA-cascade-polymer, a new blood-pool agent: Preliminary experiences
16. Characterization of N-ethyl-N-nitrosurea-induced malignant and benign breast tumors in rats by using three MR contrast agents
17. Diverse spectrum of tumors in male Sprague-Dawley rats following single high doses of N-ethyl-N-nitrosurea (ENU)
18. Neoplasms induced with high single doses of N-ethyl-N-nitrosurea in 30-day-old Sprague-Dawley rats, with special emphasis in mammary neoplasia
19. Neural, pituitary and mammary tumors in Sprague-Dawley rats treated with x-irradiation to the head and N-ethyl-N-nitrosourea (ENU) during the early postnatal period: A statistical study of tumor incidence and survival
20. ENU-induced in vitro neoplastic transformation of rat mammary epithelial cells
21. Characteristics of gadolinium-DTPA complex: A potential new NMR contrast agent
22. Pharmacocinetics of Gd-DTPA/dimeglumine after intravenous injection into healthy volunteers
23. Breast disease: Tissue characterization with Gd-DTPA enhanced profiles
24. Differentiation of benign from malignant breast masses by time-intensity evaluation of contrast enhanced MRI
25. Contrast MRI of the breast after limited surgery and radiation therapy
26. Half-Fourier, three-dimensional technique for dynamic contrast enhanced MR imaging of both breasts and axillae: Initial characterization of breast lesions
27. K-space substitution: A novel dynamic imaging technique
28. 'Keyhole' method for accelerating imaging of contrast agent uptake
29. Transport of molecules across tumor vasculature
30. Vascular and interstitial barriers to delivery of therapeutic agents in tumors
31. Barriers to drug delivery in solid tumors
32. Mammary carcinoma model: Correlation of macromolecular contrast-enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density
33. Contrast-enhanced magnetic resonance imaging of tumor-bearing mice treated with human recombinant tumor necrosis factor α
34. Assessing tumor angiogenesis using macromolecular MR imaging contrast media
35. Quantification of the extraction fraction for gadopentetate across breast cancer capillaries
36. Correlation of dynamic contrast-enhanced magnetic resonance imaging with histologic tumor grade: Comparison of macromolecular and small molecular contrast media
37. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging
38. Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR)
39. Application of the Scarff-Bloom-Richardson tumor grading system to fine needle aspirates of the breast
40. Determinants of tumor blood flow: A review
41. Angiogenesis, microvascular atchitecture, microhemodynamics, and interstitial fluid pressure during early growth of human adenocarcinoma LS174T in SCID mice
42. Vascular permeability in a human tumor xenograft: Molecular size dependence and cutoff size
43. Physiologic measurements by contrast-enhanced MR imaging: Expectations and limitations
44. Tumor characterization with dynamic contrast enhanced MRI using MR contrast agents of various molecular weights
45. MS-325, the first small-molecule blood pool agent for MRI
46. First pass myocardial imaging with MS-325, a new intravascular magnetic resonance contrast agent
47. Ultrasmall iron oxide to enhance MRA of the renal and coronary arteries: Studies in human patients